Drug makers shifting towards targeted cancer drugs – Marketwatch

The FDA approved Zytiga in April 2011 to be used in combination with a steroid called prednisone in advanced prostate cancer patients who have received prior chemotherapy treatment. The new study could support the drug’s use in a wider patient …